Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of biomarker tests for diagnosis of neuroendocrine tumours
Johannes Hofland, Wouter T. Zandee, Wouter W. de Herder
Nature Reviews Endocrinology (2018) Vol. 14, Iss. 11, pp. 656-669
Closed Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Nucleic Acid-Functionalized Metal–Organic Framework-Based Homogeneous Electrochemical Biosensor for Simultaneous Detection of Multiple Tumor Biomarkers
Jiafu Chang, Xin Wang, Jiao Wang, et al.
Analytical Chemistry (2019) Vol. 91, Iss. 5, pp. 3604-3610
Closed Access | Times Cited: 421
Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms
Johannes Hofland, Gregory Kaltsas, Wouter W. de Herder
Endocrine Reviews (2019) Vol. 41, Iss. 2, pp. 371-403
Open Access | Times Cited: 162
Biochemical Assessment of Pheochromocytoma and Paraganglioma
Graeme Eisenhofer, Christina Pamporaki, Jacques W.M. Lenders
Endocrine Reviews (2023) Vol. 44, Iss. 5, pp. 862-909
Closed Access | Times Cited: 57
Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management
Zuyi Ma, Yuanfeng Gong, Hongkai Zhuang, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 19, pp. 2305-2322
Open Access | Times Cited: 137
Evaluation and Management of Neuroendocrine Tumors of the Pancreas
Aaron T. Scott, James R. Howe
Surgical Clinics of North America (2019) Vol. 99, Iss. 4, pp. 793-814
Open Access | Times Cited: 120
Management of carcinoid syndrome: a systematic review and meta-analysis
Johannes Hofland, Aura D. Herrera‐Martínez, Wouter T. Zandee, et al.
Endocrine Related Cancer (2019) Vol. 26, Iss. 3, pp. R145-R156
Open Access | Times Cited: 77
Bioinspired Homonuclear Diatomic Iron Active Site Regulation for Efficient Antifouling Osmotic Energy Conversion
Zhe Li, Donghai Wu, Qingchen Wang, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 16
Combined deletion of MEN1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice
Mary E. Fuentes, Xiaoyin Lu, Natasha Flores, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors
Andrea Sansone, Rosa Lauretta, Sebastiano Vottari, et al.
Cancers (2019) Vol. 11, Iss. 8, pp. 1113-1113
Open Access | Times Cited: 55
Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine
Guido Rindi, Bertram Wiedenmann
Nature Reviews Endocrinology (2020) Vol. 16, Iss. 10, pp. 590-607
Closed Access | Times Cited: 52
An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms
Jiayun M. Fang, Jay Li, Jiaqi Shi
World Journal of Gastroenterology (2022) Vol. 28, Iss. 10, pp. 1009-1023
Open Access | Times Cited: 32
Neuroendocrine Neoplasms of the Gynecologic Tract
Mayur Virarkar, Sai Swarupa Vulasala, Ajaykumar C. Morani, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1835-1835
Open Access | Times Cited: 31
Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review
Martine Bocchini, Fabio Nicolini, Stefano Severi, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 39
The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future
Virginia Liberini, Martin W. Huellner, Séréna Grimaldi, et al.
Diagnostics (2020) Vol. 10, Iss. 12, pp. 1083-1083
Open Access | Times Cited: 37
Prevention and Management of Hormonal Crisis during Theragnosis with LU-DOTA-TATE in Neuroendocrine Tumors. A Systematic Review and Approach Proposal
María Isabel del Olmo-García, M.A. Muros, Martín López de la Torre Casares, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 7, pp. 2203-2203
Open Access | Times Cited: 33
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)
Irvin M. Modlin, Mark Kidd, Kjell Öberg, et al.
Annals of Surgical Oncology (2021) Vol. 28, Iss. 12, pp. 7506-7517
Closed Access | Times Cited: 32
Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up
Gitta Boons, Timon Vandamme, Laura Mariën, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 2, pp. 338-349
Open Access | Times Cited: 28
Integrative metabolomic characterization identifies plasma metabolomic signature in the diagnosis of papillary thyroid cancer
Shuang Yu, Changan Liu, Yingtong Hou, et al.
Oncogene (2022) Vol. 41, Iss. 17, pp. 2422-2430
Closed Access | Times Cited: 22
The diagnostic challenges of functioning neuroendocrine tumors: balancing accuracy, availability, and personalized care
Sara Massironi
Expert Review of Endocrinology & Metabolism (2024) Vol. 19, Iss. 2, pp. 99-101
Open Access | Times Cited: 4
A blood-based liquid biopsy analyzing soluble immune checkpoints and cytokines identifies distinct neuroendocrine tumors
Pablo Mata-Martínez, Lucía Celada, Francisco J. Cueto, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Resistance to targeted treatment of gastroenteropancreatic neuroendocrine tumors
Matthias Beyens, Timon Vandamme, Marc Peeters, et al.
Endocrine Related Cancer (2018) Vol. 26, Iss. 3, pp. R109-R130
Open Access | Times Cited: 32
Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience
Anna Malczewska, Magdalena Witkowska, Monika Wójcik-Giertuga, et al.
Neuroendocrinology (2020) Vol. 111, Iss. 4, pp. 304-319
Closed Access | Times Cited: 26
Update on the Surgical Treatment of Pancreatic Neuroendocrine Tumors
Florence Le Jeune, Abdelkader Taïbi, Sébastien Gaujoux
Scandinavian Journal of Surgery (2020) Vol. 109, Iss. 1, pp. 42-52
Open Access | Times Cited: 25
NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis
Anna Malczewska, Kjell Öberg, Beata Kos‐Kudła
Endocrine Connections (2020) Vol. 10, Iss. 1, pp. 110-123
Open Access | Times Cited: 24
Molecular Imaging of Neuroendocrine Neoplasms
Julie Refardt, Johannes Hofland, Damian Wild, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. e2662-e2670
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top